BOSTON--(BUSINESS WIRE)--Jan. 20, 2006--Point Therapeutics, Inc. (NASDAQ:POTP) announced today that it will host a live webcast on Tuesday, January 31 at 7:30 AM EST. “As the new year begins, we would like to provide our new investors and long-term shareholders a clinical update regarding the design and strategy behind our Phase 3 metastatic non-small cell lung cancer program and our on-going Phase 2 studies,” said Don Kiepert, Chairman and Chief Executive Officer.
